
    
      Study duration per participant is 2 months to estimated 16 months. Cycle lengths in this
      study are 27 days in Cycle 1 and 28 days for subsequent cycles as determined by totality of
      data collected thus far including PK/Pharmacodynamics (PD), safety and preliminary efficacy.
    
  